Top View
- FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence
- Targeting the Brain to Cure Type 2 Diabetes
- Supplementary Information
- Fibrosis Regression Observed in Treatment with Fgf19
- AXIN1 in Plasma Or Serum Is a Potential New Biomarker for Endometriosis
- Whole-Transcriptome Analysis of Fully Viable Energy Efficient Glycolytic
- Up-Regulation of FGF15/19 Signaling Promotes Hepatocellular Carcinoma in the Background of Fatty Liver Guozhen Cui1, Robert C
- The Secretome of Brown Adipose Tissue
- Actions and Mode of Actions of FGF19 Subfamily Members
- Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19–FGFR4–KLB Pathway Inhibition Vivek Subbiah 1 and Sumanta K
- The Impact of FGF19/FGFR4 Signaling Inhibition in Antitumor Activity Of
- Dissecting the Interaction of FGF8 with Receptor FGFRL1
- Theranostics FGF19/SOCE/Nfatc2 Signaling Circuit Facilitates the Self
- Regulation of Fibroblast Growth Factor 15/19 and 21 on Metabolism: in the Fed Or Fasted State Dandan Guan1,2†, Lidan Zhao3†, Daiwen Chen1,2, Bing Yu1,2 and Jie Yu1,2*
- FGF19 Subfamily Members: FGF19 and FGF21
- FGF1 and FGF19 Reverse Diabetes by Suppression of the Hypothalamic–Pituitary–Adrenal Axis
- Fibroblast Growth Factor (FGF)
- Enhanced Expression of FGF19 Predicts Poor Prognosis in Patients with Non-Small Cell Lung Cancer
- Emerging Roles of FGF Signaling in Hepatocellular Carcinoma
- FGF/FGFR Signaling in Hepatocellular Carcinoma: from Carcinogenesis to Recent Therapeutic Intervention
- FGF19’S Mitogenicity by Suppressing Its Receptor Dimerization Ability
- 3 Growth Factors
- Efficient Specification of Interneurons from Human Pluripotent Stem Cells by Dorsoventral and Rostrocaudal Modulation
- Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
- FGF19’S Mitogenicity by Suppressing Its Receptor Dimerization Ability
- Increased FGF19 Copy Number Is Frequently Detected in Hepatocellular Carcinoma with a Complete Response After Sorafenib Treatment
- (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling As a Driver Event in Hepatocellular Carcinoma
- The FGF Metabolic Axis
- Fibroblast Growth Factor (FGF) 1, FGF2, FGF17 and FGF19 Are Expressed
- Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr
- FGF8 Initiates Inner Ear Induction in Chick and Mouse
- Cross-Talk Between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma